Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Respiratory Company, LLC”

12 pharma patents match "Theravance Respiratory Company, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Theravance Respiratory Company, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Theravance Respiratory Company, LLC” · 30,257 patents in full index Clear search

  1. US 10836744

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  2. US 10590107

    Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  3. US 10358433

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  4. US 10138220

    Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  5. US 9975875

    Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted May 22, 2018 · Expires May 17, 2038

    granted

  6. US 9771350

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  7. US 9682957

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  8. US 9572802

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted

  9. US 9394275

    Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  10. US 9000173

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  11. US 8969571

    Biphenyl derivatives

    Theravance Respiratory Company, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  12. US 8816088

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.